Back to Agenda
GVP Module XVI - Risk minimisation measures: Selection of tools and effectiveness indicators (REV 3)- cont.
Speaker(s)
Thomas Goedecke, PHARMD, PHD
Senior Pharmacovigilance Specialist, European Medicines Agency, Netherlands
METHODS FOR EFFECTIVENESS EVALUATION OF RISK MINIMISATION MEASURES (RMMs)
Daniel Morales, MD, PHD, MRCP
Epidemiologist, European Medicines Agency, Netherlands
MONITORING THE EFFECTIVENESS OF RMMs: FROM THEORY TO PRACTISE
Priya Bahri, PHD
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy), European Medicines Agency, Netherlands
Q&A AND PANEL DISCUSSION INCLUDING:
Viola Macolic Sarinic, DRSC, MD, MSC
Scientific Officer, European Medicines Agency, Netherlands
Q&A AND PANEL DISCUSSION INCLUDING:
Have an account?
